GPT and neoplasm: Together, these data provide evidence of tumor TMM heterogeneity with the coexistence of both ALT and telomerase activity in the same tumor and this phenotype is conserved in mouse orthotopic xenograft, thereby providing a unique opportunity to concurrently test in vivo ALT and telomerase inhibitors.